Stat

STAT+: Eli Lilly announces $27 billion investment in U....

Eli Lilly plans to spend $27 billion to build new drug manufacturing sites in th...

STAT+: Pharmalittle: We’ve reading about abortion pill ...

GenBioPro, the largest manufacturer of abortion pills in the U.S., is wading int...

Roger Perlmutter startup raises $350 million

The biotech news stories you need to read, brought to you by The Readout.

Third recipient of pig kidney heads home from hospital

Plus more health news stories to stay on top of this morning.

How ultra-processed foods captured the baby and toddler...

Experts are calling for more focus on how ultra-processed foods are marketed to ...

Opinion: RFK Jr.’s dangerous misuse of ‘informed consen...

Giving people an uncontextualized list of possible vaccine side effects is not t...

Q&A: How Trump’s USAID freeze halted the effort to deve...

Glenda Gray, program director of a research consortium, talked with STAT about t...

STAT+: Budget bill passes in House, but clashes over sp...

The House budget bill that passed does not include specific policies, and target...

STAT+: Trump signs order doubling down on making health...

President Trump on Tuesday reaffirmed a priority from his first term: making hea...

STAT+: A bill is re-introduced in Congress to revise pr...

The bill would allow Medicare to begin negotiating with pharmaceutical companies...

STAT+: A bill is re-introduced in Congress to erase dis...

The bill would allow Medicare to begin negotiating with pharmaceutical companies...

CDC will no longer process transgender data

The agency's decision will likely affect a number of federal health surveillance...

A TikTok video spurs alarm about Medicare coverage for ...

In the latest edition of STAT Health Tech newsletter: Telehealth risks becoming ...

Lilly expands its Zepbound vial offering, as Hims pulls...

Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and...

STAT+: Trump’s FDA navigates layoffs, exits, and a new ...

This week in health care politics and policy: FDA rehires staff, former drug reg...

Wins for bulk milk testing and deafness research

In today's Morning Rounds newsletter, wins for bulk milk testing and deafness re...

STAT+: Pharmalittle: We’re reading about Zepbound price...

Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower ...

STAT+: Some NIH study sections will resume grant review...

While some NIH study sections will resume, advisory council meetings, which make...

STAT+: Eli Lilly to lower price of Zepbound vials, offe...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepboun...

STAT+: Under siege after a tragedy, UnitedHealth grappl...

Heightened security at UnitedHealth Group's Minnesota headquarters in the wake o...

Opinion: ‘Ultra-processed food’ is too broad a term to ...

Legislatures, governors, government agencies, and plaintiff attorneys are taking...

Covid, inflation, and Supreme Court blamed for steep dr...

Native American leaders were taken aback to see 22% fewer American Indian or Ala...

Opinion: What academic research could learn from colleg...

Just as college sports have had to change, so does basic science research at uni...

STAT+: Some NIH study sections will resume reviewing gr...

While some NIH study sections will resume, advisory council meetings, which make...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.